CSPC Pharmaceutical Group... (CHJTF)
OTC: CHJTF
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 05, 2025, 12:35 PM
1.27
0.00%
After-hours: Aug 21, 2025, 04:00 PM EDT
CSPC Pharmaceutical Cash Flow Statement
Financials in HKD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | 6.25B | 6.42B | 9.03B | 9.83B | 9.94B | 11.73B | 12.11B | 10.47B | 10.17B | 10.2B | 10.33B | 10.01B | 9.48B |
Depreciation & Amortization | 678.6M | 678.6M | 1.32B | 1.32B | 1.24B | 1.88B | 1.82B | 1.82B | 1.74B | 1.75B | 1.62B | 1.52B | 1.42B |
Stock-Based Compensation | 227.43M | 298.24M | 393.32M | 400.08M | 273.03M | 302.79M | 164.66M | 100.57M | n/a | 100.57M | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | -1.23B | -1.23B | -1.23B | -188.23M | 1.04B | 1.04B | n/a | 1.04B | n/a | n/a | n/a |
Other Non-Cash Items | -5.63B | -5.86B | -2.03B | -2.83B | -1.44B | -435.15M | -1.23B | 468.83M | 3.71B | 3.17B | 4.27B | 4.18B | 3.19B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | -4.04B | -4.04B | -4.04B | -3.69B | 352.02M | 352.02M | -784.28M | -1.33B | -1.68B | -1.68B | n/a |
Operating Cash Flow | 1.53B | 1.53B | 4.68B | 4.68B | 4.78B | 8.59B | 10.86B | 10.86B | 11.35B | 11.68B | 11.3B | 10.99B | 11.25B |
Capital Expenditures | -697.58M | -697.58M | -1.68B | -1.68B | -2.14B | -3.74B | -3.93B | -3.93B | -4.39B | -4.1B | -3.3B | -2.77B | -2.59B |
Cash Acquisitions | n/a | n/a | n/a | n/a | 496.21M | 450.73M | 162.46M | 162.46M | -244.54M | -258M | -1.9M | 620.44M | -102.44M |
Purchase of Investments | n/a | n/a | n/a | n/a | -4.5B | -4.5B | -11.18B | -11.18B | -10.34B | -8.61B | -13.22B | -11.6B | -9.88B |
Sales Maturities Of Investments | n/a | n/a | 647.85M | 647.85M | 7.29B | 7.29B | 7.65B | 7.65B | 8.14B | 5.31B | 8.31B | 10.86B | 7.75B |
Other Investing Acitivies | -1.59B | -1.59B | -1.53B | -1.53B | -173.14M | 232.5M | 165.16M | 165.16M | 91.77M | 450.51M | 15.65M | 14.91M | -49.96M |
Investing Cash Flow | -2.29B | -2.29B | -2.56B | -2.56B | 970.26M | -266.49M | -7.14B | -7.14B | -6.74B | -7.21B | -8.2B | -2.87B | -4.87B |
Debt Repayment | -85.92M | -85.92M | -85.92M | -85.92M | -81.99M | -81.99M | 238.58M | 238.58M | 320.58M | 320.58M | 126.14M | -194.43M | -238.32M |
Common Stock Repurchased | -379.49M | -379.49M | -648.72M | -648.72M | -495.82M | -495.82M | -243.24M | -243.24M | -334.36M | -335.58M | -335.58M | -318.94M | -0.49 |
Dividend Paid | -1.65B | -1.65B | -3.32B | -3.32B | -3.04B | -4.26B | -3.81B | -3.81B | -3.32B | -3.42B | -3.28B | -3.79B | -2.82B |
Other Financial Acitivies | -347.84M | -347.84M | -51.14M | -51.14M | 356.38M | 279.35M | -56.24M | -56.24M | -109.71M | -190.09M | -130.47M | -104.43M | 159.79M |
Financial Cash Flow | -2.46B | -2.46B | -3.84B | -3.84B | -2.98B | -4.28B | -3.83B | -3.83B | -3.51B | -3.59B | -3.59B | -4.49B | -2.97B |
Net Cash Flow | 8.05B | 8.05B | 9.77B | 9.77B | 1.45B | -6.59B | -9.04B | -9.04B | 1.85B | -7.13B | 1.97B | 4.76B | 4.9B |
Free Cash Flow | 834.08M | 834.08M | 3B | 3B | 2.64B | 4.85B | 6.93B | 6.93B | 6.97B | 7.57B | 8B | 8.22B | 8.66B |